BRGX — BioRegenx Balance Sheet
0.000.00%
- $15.02m
- $17.13m
- $2.34m
Annual balance sheet for BioRegenx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.094 | 0.024 | 0.001 | 0.125 | 0.058 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.001 | 0 | — | 0.105 | 0.015 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.095 | 0.024 | 0.001 | 0.653 | 0.308 |
Net Property, Plant And Equipment | — | — | — | 0.014 | 0.201 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 0.368 | 0.128 | 0.059 | 0.866 | 0.509 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.042 | 0.014 | 0.065 | 2.79 | 3.63 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.19 | 0.212 | 0.261 | 2.94 | 3.89 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.178 | -0.084 | -0.202 | -2.07 | -3.38 |
Total Liabilities & Shareholders' Equity | 0.368 | 0.128 | 0.059 | 0.866 | 0.509 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |